PDF(Pubmed)
Abstract：
Subcutaneous implantation is an unexpected complication of thyroid surgery. Our study aimed to analyze the clinical features and outcomes of implantation after thyroid surgery. We retrospectively searched for the patients with implants of thyroid tumor after surgery from our database prior to August 2023. The clinical and pathological data were reviewed. Six female patients with a mean age of 33.6 ± 13.3 years were enrolled in this study. There was a rare case with mucinous adenocarcinoma, three follicular thyroid carcinoma, and two papillary thyroid carcinoma. The case with primary enteric adenocarcinoma of thyroid with subcutaneous implantation was first reported. The patient with mucinous adenocarcinoma received six courses of TP regimen chemotherapy. Five cases received radioactive iodine therapy. After a mean of 69.5 months of follow-up, one case recurred in the lateral region, and no metastasis or recurrence happened in the other five cases. Although the implantation after thyroid surgery is uncommon, the cases serve as a reminder to take greater care to avoid implantation.
摘要：
皮下植入是甲状腺手术的意外并发症。我们的研究旨在分析甲状腺手术后植入的临床特征和结果。我们在2023年8月之前从我们的数据库中回顾性搜索了手术后植入甲状腺肿瘤的患者。回顾性分析临床及病理资料。本研究招募了6名平均年龄为33.6±13.3岁的女性患者。有一例罕见的粘液腺癌,三种滤泡性甲状腺癌，和两个甲状腺乳头状癌。首次报道原发性甲状腺肠腺癌皮下植入的病例。黏液腺癌患者接受了6个疗程的TP方案化疗。5例接受放射性碘治疗。经过平均69.5个月的随访，一例在侧区复发，其余5例均无转移或复发。尽管甲状腺手术后的植入并不常见，这些病例提醒我们要更加小心，避免植入。
